Extract notice to the Minister

Teva-Lisdexamfetamine

Common name / Subject : lisdexamfétamine (dimésylate de)
Name of the manufacturer : Teva Can
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription - Avec conditions

Minister's decisions
Inscrire aux listes des médicaments - Médicament d'exception

Evaluation published on August 14, 2024

Subscribe to our newsletter now

Subscription